atovaquone oral suspension 750 mg/5ml

Glenmark Pharma gets final approval from USFDA for Atovaquone Oral Suspension

by

Glenmark Pharmaceuticals Inc., USA has been granted final approval by the United States Food & Drug Administration (USFDA) for Atovaquone Oral Suspension USP, 750 mg/5 mL, a generic version of Mepron Oral Suspension, 750 mg/5 mL, of GlaxoSmithKline LLC. According to IQVIA sales data, the Mepron Oral Suspension, 750 mg/5 mL market2 achieved annual sales … Read more

Lupin launches generic Atovaquone Oral Suspension USP in US

by

Lupin has launched Atovaquone Oral Suspension USP, 750 mg/5 mL having received an approval from the United States Food and Drug Administration (USFDA) earlier. Lupin’s Atovaquone Oral Suspension USP, 750 mg/5 mL is the generic equivalent of Glaxosmithkline LLC’s Mepron oral suspension 750 mg/5 ml. It is indicated for the prevention of Pneumocystis jirovecii pneuomonia … Read more